Early research (Phase 1)Study completedNCT03441815What this trial is testingXC8 Safety, Tolerability and Pharmacokinetics in Healthy VolunteersWho this might be right forAsthma PHARMENTERPRISES LLC 28
Early research (Phase 1)Study completedNCT05853835What this trial is testingFirst-in-Human Trial in Healthy Adult Volunteers to Evaluate Safety, Tolerability and PK of LAPIX Study Drug; LPX-TI641Who this might be right forAutoimmune DiseasesMultiple Sclerosis LAPIX Therapeutics Inc. 72
Early research (Phase 1)Study completedNCT03553316What this trial is testingDrug-Drug Interaction Between PK101-001 and PK101-002Who this might be right forArthritis PMG Pharm Co., Ltd 49
Early research (Phase 1)Study completedNCT00487916What this trial is testingPhase 1 Study of the Safety, Reactogenicity, and Immunogenicity of AMA1-C1/ISA 720: Blood Stage Vaccine for Plasmodium FalciparumWho this might be right forMalaria National Institute of Allergy and Infectious Diseases (NIAID) 150
Early research (Phase 1)Looking for participantsNCT07765706What this trial is testingAssess the Safety, Tolerability and Pharmacokinetics (PK) of INS1033 in Healthy ParticipantsWho this might be right forHealthy Volunteers Insmed Incorporated 116
Early research (Phase 1)Study completedNCT06386328What this trial is testingA Clinical Trial to Evaluate the Food Effect of CKD-378Who this might be right forType II Diabetes Mellitus Chong Kun Dang Pharmaceutical 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT06845202What this trial is testingEvaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DMWho this might be right forObese or Overweight Healthy VolunteersType 2 Diabetes Mellitus (T2DM) Alnylam Pharmaceuticals 105
Early research (Phase 1)Study completedNCT05148481What this trial is testingEvaluate Safety and Pharmacokinetics of BIIB104 in Healthy Japanese and Non-Japanese ParticipantsWho this might be right forHealthy Volunteer Biogen 31
Early research (Phase 1)Study completedNCT03273192What this trial is testingCinnoRA (Adalimumab-CinnaGen) And Adalimumab (Humira) In Healthy SubjectsWho this might be right forBioequivalencePhase 1 Cinnagen 74
Early research (Phase 1)Study completedNCT03867331What this trial is testingTo Assess the Safety, Immunogenicity and Efficacy of VLPM01 in Healthy, Malaria-Naïve VolunteersWho this might be right forMalaria,Falciparum VLP Therapeutics 36
Early research (Phase 1)Study completedNCT05368831What this trial is testingOpen-label Study to Evaluate the Effects of NST-1024 on the PK of Multiple Drugs in Healthy SubjectsWho this might be right forHealthy Volunteers NorthSea Therapeutics B.V. 24
Early research (Phase 1)Study completedNCT04519437What this trial is testingStudy Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19Who this might be right forHealthyChronic Stable Illness Regeneron Pharmaceuticals 974
Early research (Phase 1)Study completedNCT04274075What this trial is testingEvaluation of the Relative Bioavailability and Food Effect of GDC-9545 in Healthy Females of Non-Childbearing PotentialWho this might be right forHealthy Volunteers Genentech, Inc. 18
Early research (Phase 1)Study completedNCT02389881What this trial is testingSafety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy ParticipantsWho this might be right forHealthy Volunteers Takeda 40
Early research (Phase 1)Study completedNCT05385575What this trial is testingEvaluate Effects of KN056 in Healthy ParticipantsWho this might be right forType 2 Diabetes Suzhou Alphamab Co., Ltd. 46
Early research (Phase 1)Study completedNCT03590600What this trial is testingA Single Ascending Dose Study of BTZ043Who this might be right forTuberculosisTuberculosis, PulmonaryBacterial Infections+2 more Michael Hoelscher 30
Early research (Phase 1)Study completedNCT00936871What this trial is testingThe Effect Of Lersivirine (UK-453,061) On Qt Intervals In Healthy SubjectsWho this might be right forHealthy Volunteers Pfizer 66
Early research (Phase 1)Study completedNCT03723395What this trial is testingA Drug-Drug Interaction Study in Healthy Volunteers of the Effects of TucatinibWho this might be right forDrug-drug Interaction Seagen Inc. 116
Early research (Phase 1)Study completedNCT04372407What this trial is testingAssess the Effect of a Strong CYP3A Inhibitor, on Surufatinib in Healthy SubjectsWho this might be right forHealthy Hutchison Medipharma Limited 13
Early research (Phase 1)WithdrawnNCT03131700What this trial is testingBioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovatorWho this might be right forHealthy TRPHARM